Notice of Results

RNS Number : 3784W
Byotrol PLC
01 August 2018
 

1 August, 2018

 

Byotrol plc

("Byotrol" or the "Company") 

 

Notice of Results

 

 

Byotrol plc, the specialist anti-microbial technology company, announces that it will be releasing its audited results for the year ended 31 March 2018 no later than 24 August, 2018.

 

 

 

Enquiries:

                                                                                                                                                     

David Traynor - Chief Executive, Byotrol plc                                                                        01925 742 000

David Paton - Investor Relations                                                                                          07714 190 474

 

 

finnCap Ltd                                                                                                                           020 7220 0500 (Nominated Adviser & Broker)

Geoff Nash/Kate Bannatyne- Corporate Finance

Richard Chambers - Corporate Broking

 

 

Notes to Editors:

 

Byotrol plc (BYOT.L), quoted on AIM, is a specialist developer of antimicrobial technologies. Our patented suite of technologies deliver powerful broad-spectrum efficacy with long-lasting performance, optimised against commonly occurring and industry-specific pathogens.

 

Founded in 2005, the Company has developed advanced antimicrobial technologies that create easier, safer and cleaner lives for everyone.

 

For more information, please go to www.byotrol.co.uk

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORWGUGGMUPRGQG

Companies

Byotrol (BYOT)
UK 100

Latest directors dealings